When was Optimapharm founded?

Optimapharm was founded in 2005 and raised its 1st funding round 13 years after it was founded.

Where is Optimapharm located?

Optimapharm is headquartered in Zagreb, Croatia.

Who is the current CEO of Optimapharm?

Gordana Gregurić thistle of Optimapharm.

How many employees does Optimapharm have?

As of Mar 31, 2026, the latest employee count at Optimapharm is 297.

Is Optimapharm a funded company?

Optimapharm is a funded company, having raised a total of $11.5M across 3 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Oct 23, 2018.

When was the latest funding round of Optimapharm?

Optimapharm's latest funding was a $***** Grant (prize money) round on Apr 01, 2021, with participation from 1 investor.

What is the annual revenue of Optimapharm?

Annual revenue of Optimapharm is €60.1K as on Dec 31, 2024.

Where does Optimapharm rank among its competitors?

Optimapharm ranks 47th amongst 350 active competitors, of which 14 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was ClinChoice, which secured $150M in Jul, 2022.

Who are the top competitors of Optimapharm?

Optimapharm's top competitors include Emmes, Syneos Health and TFS. Among them, ClinChoice secured the most recent funding round in July, 2022.

Optimapharm - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Optimapharm is a European-based CRO focused on clinical research services to pharmaceutical, biotechnology and medical device companies. It provides services from phase I to IV along with observational studies in therapeutic areas such as oncology, psychiatry/CNS, cardiovascular and metabolic diseases. Its other services include regulatory & ethics, monitoring services, project management, data management, medical writing, biostatistics and pharmacovigilance.

Website: optimapharm.eu
Email ID: *****@optimapharm.eu

Key Metrics

Founded Year

2005

Location

Zagreb, Croatia

Stage

Series A

Total Funding

$11.5M in 3 rounds

Latest Funding Round

Grant (prize money), Apr 01, 2021, $*****

Investors

Rohatyn Group & 4 more

Ranked

47^th among 350 active competitors

Annual Revenue

€60.1K as on Dec 31, 2024

Employee Count

297 as on Mar 31, 2026

Investment & Acquisitions

Crown CRO & 1 more

Similar Companies

Emmes & 415 more

View Optimapharm's full profile

Optimapharm is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
OPTIMAPHARM.EU CIN: 91380434993 , Croatia, Active		-	-
OPTIMA INTERNATIONAL d. o. o. CIN: 81217565783 , Croatia, Active	Nov 22, 2016	$65.1K (As on Dec 31, 2024)	-

Optimapharm has raised a total funding of $11.5M over 3 rounds. Its first funding round was on Oct 23, 2018. Its latest funding round was a Grant (prize money) round on Apr 01, 2021 for $*****. 1 investor participated in its latest round. Optimapharm has 5 institutional investors.

Here is the list of recent funding rounds of Optimapharm:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 01, 2021	4255265	Grant (prize money)	4219595	8555479	6464148	4417704
May 11, 2020	5948397	Series A	7814302	1403911	2382246	6880938
Oct 23, 2018	1832551	Series A	1889215	9184332	Mezzanine Management	1152376

Access funding benchmarks and valuations. Sign up today!

View details of Optimapharm's funding rounds and investors

The founders of Optimapharm are Igor Cicak and Gordana Gregurić thistle.

Here are the details of Optimapharm's key team members:

Igor Cicak: Co-Founder of Optimapharm and founder of 2 other companies, Adria Dental Group and Provectus Capital Partners.
Gordana Gregurić thistle: Co-Founder & CEO & COO of Optimapharm.

View details of Optimapharm's Founder profiles and Board Members

Optimapharm's employee count trend

Optimapharm has 297 employees as of Mar 26. Here is Optimapharm's employee count trend over the years:

Uncover Optimapharm's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Optimapharm include Emmes, Syneos Health and TFS. Here is the list of Top 10 competitors of Optimapharm, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Emmes 1977, United States, Acquired	Provider of outsourced CRO services	-	Behrman Capital, Apollo Investment Corporation ... & 2 others	65/100
2nd	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Nordea, Adams Street Partners & 2 others	63/100
3rd	TFS 1996, Lund (Sweden), Acquired	A global mid-service CRO providing clinical research services	-	-	63/100
4th	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	61/100
5th	ClinChoice 1995, Fort Washington (United States), Series E	CRO focused on data management, regulatory affairs and consulting services	$212M	Goldman Sachs, Legend Capital & 7 others	58/100
6th	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, BPEA & 2 others	55/100
7th	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Vedanta Capital, Boston Millennia Partners ... & 2 others	55/100
8th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	54/100
9th	hVIVO 1998, London (United Kingdom), Public	Provider of cell based assays, field trial, and molecular services for biopharma sector	-	Woodford Investment Management, IP Group	53/100
10th	Medelis WCCT Global 1998, Cypress (United States), Acquired	Paid clinical trials in Los Angeles and Orange County, California	$17M	Medivate Partners, Forward Equity Partners ... & 1 others	53/100
47th	Optimapharm 2005, Zagreb (Croatia), Series A	CRO proving clinical research and observational study services	$11.5M	Kartesia, Keyhaven Capital Partners & 3 others	38/100